Finer

Corona and Sue Bird Maximize Game Day Fandom With a New Collaboration

Retrieved on: 
Wednesday, June 7, 2023
Constellation, Constellation Brands, Sponsor, Fortune: Million Pound Giveaway, Finer, Retirement, Sweepstake, Corona (beer), Relaxation, Hotel

“For the first time in a long time, I am putting my feet up and enjoying games as a fan.

Key Points: 
  • “For the first time in a long time, I am putting my feet up and enjoying games as a fan.
  • And you know I had to have Corona create a custom Finer Recliner to do that.
  • Being a sports fan can be an intense experience, but being a Corona sports fan is different.
  • The Corona Sue Bird Finer Recliner Sweepstakes is sponsored by Crown Imports LLC.

Septerna Appoints Jeffrey Finer, MD, PhD, as Chief Executive Officer

Retrieved on: 
Thursday, September 22, 2022
Biotechnology, General Health, Infectious Diseases, Health, Pharmaceutical, GPCR, The Sun Sessions, Engineering, Third Rock Ventures, Finer, MD, Norwest Venture Partners, Growth, Industry, Therapy, Patient, Jeff, Technology, Leadership, Biography, Doctor of Philosophy, Science, Board, Research, Drug discovery, G protein-coupled receptor, Maze, Fine chemical, Cytokinetics

Septerna, a biotechnology company discovering and advancing novel small molecule medicines targeting G protein-coupled receptors (GPCRs), today announced that Jeffrey Finer, MD, PhD, has been named the companys full-time Chief Executive Officer, transitioning from his current role as interim CEO.

Key Points: 
  • Septerna, a biotechnology company discovering and advancing novel small molecule medicines targeting G protein-coupled receptors (GPCRs), today announced that Jeffrey Finer, MD, PhD, has been named the companys full-time Chief Executive Officer, transitioning from his current role as interim CEO.
  • Septerna was launched in January of 2022 with a $100 million Series A financing led by Third Rock Ventures.
  • Under Jeffs leadership, Septerna has built a powerful drug discovery engine and has advanced a rapidly growing early pipeline of novel GPCR drug candidates.
  • Septerna was launched in 2022 by scientific founders who have made groundbreaking GPCR discoveries and by founding investor Third Rock Ventures.

Prophix Expands Leadership Team with Key Senior Executive Hires

Retrieved on: 
Wednesday, June 15, 2022
People, Chief revenue officer, Solution, Culture, CPM, Brigham Young University Museum of Peoples and Cultures, MISSISSAUGA, SAS, Software as a service, Business performance management, Technology, ADP, Australian Energy Market Operator, CEO, Cisco Systems, Forecasting, Product management, Finer, Marketing, Growth, Investment, IBM, Panasonic, Verizon Communications, Automation, Software, Hewlett-Packard, Klipfolio dashboard, AI, Secureworks, Multimedia, VP, EagleView Technologies, Marines, Hitachi, Workiva, Goal, Risk, Organization, Management, Cognos

MISSISSAUGA, ON, June 15, 2022 /PRNewswire/ -- Prophix Software, a global leader in mid-market Corporate Performance Management (CPM) software, announced today new senior leadership hires, including appointments to the Chief Revenue Officer, Chief Marketing Officer, and several critical vice president roles. These highly experienced and accomplished executives will play a key role in priming Prophix for continued rapid growth across the globe.

Key Points: 
  • These highly experienced and accomplished executives will play a key role in priming Prophix for continued rapid growth across the globe.
  • "Exceptional people are what make Prophix the innovative and fast-growing organization it is, and I'm proud to welcome these talented and experienced senior leaders to our team," said Alok Ajmera, President and CEO of Prophix Software.
  • Tad Finer, Chief Revenue Officer: A seasoned sales executive with deep global experience, Finer joins Prophix from EagleView Technologies, where he served as Chief Revenue Officer.
  • Steve Hardy, Chief Marketing Officer: Hardy joins Prophix with over 20 years of experience in B2B SaaS marketing in high-growth businesses.